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GenBank accession numbers for 
the M. yongonense strains identified in 
this study (FI-13004 and FI-13005) are 
KF224989–KF224999.
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Subcutaneous  
Infection with  
Dirofilaria spp. 
Nematode in  
Human, France
To the Editor: The article by 
Foissac et al. titled Subcutaneous 
infection with Dirofilaria immi-
tis nematode in human, France (1) 
presents an interesting and challeng-
ing diagnostic dilemma. The paper 
described, but did not illustrate, the 
worm as having a strongly ridged ex-
ternal surface of the cuticle–a feature 
known not to exist on Dirofilaria im-
mitis, the dog heartworm. However, 
molecular sequencing of the speci-
men demonstrated much closer simi-
larity to D. immitis than to D. repens, 
the most common cause of zoonotic 
subcutaneous dirofilariasis infection 
in Europe. 
Well-described morphologic fea-
tures of parasites, including in tissue 
sections, have long been the standard 
for diagnosis. More recently, molecu-
lar diagnostics have helped in many of 
these difficult cases. However, in some 
cases, the morphology and molecular 
diagnosis are discordant. On the basis 
of the data in the article, the worm does 
not seem to represent D. repens. A more 
likely possibility is some other species 
for which no sequences are yet avail-
able for comparison. In such a worm, 
the regions sequenced must be similar 
to D. immitis, and distinct from D. re-
pens, to achieve the observed results. 
When one encounters a case such 
as this, where well-validated mor-
phologic features (Figure) are con-
tradictory to the molecular analysis, 
one must exercise caution in arriving 
at a final diagnosis. One disadvantage 
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Figure. Cross-section of the filarial nematode seen in the subcutaneous nodule on the 
thigh of a woman in France. The features, as described in the original report (1), include 
prominent, longitudinal ridging of the cuticle (arrows), 2 reproductive tubes, and the 
intestine (asterisk). Scale bar indicates 50 µm. Image courtesy of Jean-Philippe Dales.
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of morphologic and molecular diag-
nostics is an absence of information 
on poorly described and character-
ized pathogens or new pathogens that 
have yet to be identified. No good 
algorithm exists to resolve these 
conflicts other than to explore all 
possibilities. The diagnosis in the de-
scribed case is probably best left as a 
Dirofilaria species of the Dirofilaria 
(Nochtiella) type, members of which 
exhibit marked cuticular ridging, and 
not D. (Dirofilaria) immitis type, 
members of which have as a feature 
an absence of cuticular ridging.
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In Response: We agree with  Eb-
erhard (1) that it is difficult to make 
a species identification when data de-
rived from morphologic examinations 
do not correlate with those of mo-
lecular diagnostics. Errors may be the 
result of poor indexing of sequences 
deposited in sequence databases or 
inaccurate estimation of the degree of 
genomic polymorphisms within a spe-
cies and between closely related spe-
cies. On the other hand, a morphologic 
difference between 2 organisms, if it 
is associated with only 1 characteris-
tic, should not be considered sufficient 
to classify them as 2 distinct species. 
Such a phenotypic variation may be 
the result of a single mutation or de-
letion. Consequently, the absence of 
a certain character does not exclude 
the categorization of an organism as a 
given species. 
Molecular identification of the 
Dirofilaria spp. worm in our clinical 
case was made on the basis of 2 dis-
tinct sequences, each of which exhib-
ited marked differences between D. 
immitis and D. repens (2). The first 
sequence targeted internal transcribed 
spacer regions of ribosomal genes and 
revealed up to 100% homology with 
D. immitis sequences from GenBank, 
whereas a maximum homology of 
80% was observed with D. repens se-
quences from GenBank. The second 
sequence targeted the cytochrome 
oxidase 1 gene and showed 100% 
homology with D. immitis, whereas 
<90% homology was observed for 
D. repens. For both analyzed targets, 
GenBank contained several sequences 
for D. immitis and D. repens that were 
deposited by various investigators, 
and all sequences yielded consistent 
results. Therefore, there is no basis to 
suggest that the sequences deposited 
in GenBank were incorrect. 
Nevertheless, we agree that an 
alternate hypothesis is possible. The 
worm reported in our article could 
conceivably belong to a species that 
differs slightly from both D. immitis 
and D. repens, displaying morpho-
logic similarities with D. repens but 
being more closely associated with D. 
immitis at the genomic level.
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Many health professionals rely 
on journal articles to keep up with ad-
vances in their field because textbooks 
are often 1–2 years out of date by the 
time they come to press, and are far 
more expensive than the occasional 
PDF downloaded from a university 
library Web site. This 2-volume text 
on cytomegalovirus (CMV) is costly 
and cites data from before 2012, but 
provides a solid foundation on which 
to apply new findings. Volume I is 
mainly focused on the basic science 
of and related animal experiments on 
CMV; volume II is aimed at the clini-
cal reader, again with chapters on rele-
vant animal model studies. Each chap-
ter reads as a short review article, and 
is easily digestible. Many well-recog-
nized experts in this field contributed 
content, which should be reassuring 
to the reader. The text and referencing 
style are easy to read and the figures 
and tables are illustrative and helpful. 
The volumes come in a compact size, 
making them convenient to carry, and 
also are downloadable as eBooks.
Volume I gives in-depth over-
views of primate and murine CMVs, 
CMV metabolomics, miRNAs, and 
proteomics. Most of the chapters are 
dedicated to viral gene expression and 
function and virus interaction with hu-
man host cells, describing immune re-
sponse, aspects of viral tropism, entry, 
pathogenesis, and latency. The termi-
nology used in Volume I is specialized 
and may be difficult for readers who 
do not work in these fields.
Volume II covers essential clini-
cal background: the epidemiology of 
CMV infections in pregnancy, CMV 
infections in solid and bone marrow 
transplants, CMV therapy and drug re-
sistance, diagnostic methods, and vac-
cine development. Additional chapters 
describe the host immune response to 
CMV infection, and mechanisms of 
infection in specific targets, such as 
the placenta.
Chapters in both volumes are de-
tailed and clearly written; the editors 
are to be commended on maintaining 
this standard. However, additional de-
tail and discussion (i.e., pros and cons) 
about alternative targets for CMV PCR 
monitoring of transplant patients, such 
as pp65 antigen and pp67 mRNA ver-
sus DNA, would have been helpful. 
Also, an in-depth chapter on the char-
acteristics of reinfecting or superinfect-
ing strains of CMV in various clinical 
situations would be useful; such strains 
are frequently referred to without de-
scription throughout the clinical text. 
Perhaps one surprising omission on the 
clinical side is a chapter comparing and 
contrasting the various clinical guide-
lines for the treatment of CMV infec-
tions in transplant patients; this would 
highlight differences in how published 
data are interpreted.
Chapter II.23, Putative Disease 
Associations with Cytomegalovirus: a 
Critical Survey, explores the possible 
role of CMV as an etiologic agent for 
specific clinical syndromes, including 
glioblastomamultiforme, cardiovas-
cular disease, and the role that CMV 
may play in immunosenescence. This 
makes fascinating and educational 
reading, especially in how the authors 
tease out the relevant (and irrelevant) 
evidence for and against these poten-
tial etiologic roles.
The price tag is considerable, 
although the 2 volumes can be pur-
chased separately (http://www.hori-
zonpress.com/hsp/supplementary/
cmv2/cmv2-vol1-vol2.html). As a 
medical–clinical virologist, I find Vol-
ume II to be a useful reference text. 
Those working on the basic virology 
of CMV may consider Volume I a use-
ful addition to their libraries. These 
volumes give comprehensive, yet suc-
cinct overviews of the current state of 
knowledge of many aspects of CMV 
and are detailed enough to satisfy 
most readers.
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